Systematic review and network meta-analysis of interventions for fibromyalgia: a protocol.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3610251)

Published in Syst Rev on March 13, 2013

Authors

Jason W Busse1, Shanil Ebrahim, Gaelan Connell, Eric A Coomes, Paul Bruno, Keshena Malik, David Torrance, Trung Ngo, Karin Kirmayr, Daniel Avrahami, John J Riva, Peter Struijs, David Brunarski, Stephen J Burnie, Frances LeBlanc, Ivan A Steenstra, Quenby Mahood, Kristian Thorlund, Victor M Montori, Vishalini Sivarajah, Paul Alexander, Milosz Jankowski, Wiktoria Lesniak, Markus Faulhaber, Małgorzata M Bała, Stefan Schandelmaier, Gordon H Guyatt

Author Affiliations

1: Department of Anesthesia, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8S 4K1, Canada. bussejw@mcmaster.ca

Articles cited by this

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36

Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50

Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08

Interaction revisited: the difference between two estimates. BMJ (2003) 11.97

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain (2005) 11.80

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77

Sifting the evidence-what's wrong with significance tests? BMJ (2001) 9.50

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol (1997) 9.01

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89

The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum (1995) 7.97

Going from evidence to recommendations. BMJ (2008) 7.30

What is "quality of evidence" and why is it important to clinicians? BMJ (2008) 6.99

Evaluation of networks of randomized trials. Stat Methods Med Res (2007) 4.70

Management of fibromyalgia syndrome. JAMA (2004) 4.47

Indirect comparisons of competing interventions. Health Technol Assess (2005) 4.33

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain (2003) 4.24

Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid. J Clin Epidemiol (2011) 2.69

Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum (2009) 2.54

The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis (2001) 2.50

Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain (2009) 2.49

Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47

The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol (1999) 2.44

Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics (2006) 2.43

A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med (1999) 2.28

How to use an article reporting a multiple treatment comparison meta-analysis. JAMA (2012) 2.28

Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain (2006) 2.23

Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials. Pain (2009) 1.93

Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract (1999) 1.91

Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum (1997) 1.85

Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials. Pain (2008) 1.82

Is the Jadad score the proper evaluation of trials? J Rheumatol (2006) 1.80

Primary fibromyalgia syndrome--an outcome study. Br J Rheumatol (1993) 1.73

Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum (2009) 1.70

Medically unexplained symptoms--GPs' attitudes towards their cause and management. Fam Pract (2001) 1.67

Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol (2006) 1.59

Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA (2009) 1.58

Exercise for fibromyalgia: a systematic review. J Rheumatol (2008) 1.55

Unexplained symptoms in primary care: perspectives of doctors and patients. Gen Hosp Psychiatry (2000) 1.49

Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics (2000) 1.45

Acupuncture for fibromyalgia--a systematic review of randomized clinical trials. Rheumatology (Oxford) (2006) 1.38

Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis (2012) 1.31

Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology (Oxford) (2008) 1.31

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurol (2008) 1.28

Why do doctors find some patients difficult to help? Q J Med (1994) 1.28

Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database Syst Rev (2000) 1.23

Work and disability status of persons with fibromyalgia. J Rheumatol (1997) 1.20

Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med (2000) 1.17

Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia. Clin J Pain (2002) 1.17

Fibromyalgia versus rheumatoid arthritis: a longitudinal comparison of the quality of life. J Rheumatol (1995) 1.16

Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability. Res Synth Methods (2011) 1.15

A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis. Altern Ther Health Med (2001) 1.13

Chronic widespread musculoskeletal pain - a comparison of those who meet criteria for fibromyalgia and those who do not. Eur J Pain (2007) 1.13

A comprehensive review of 46 exercise treatment studies in fibromyalgia (1988-2005). Health Qual Life Outcomes (2006) 1.13

Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis. Arthritis Rheum (2004) 1.13

Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units. Health Qual Life Outcomes (2010) 1.09

[Systematic review of pharmacologic treatment in fibromyalgia]. Med Clin (Barc) (2005) 1.09

Efficacy of acupuncture for the treatment of fibromyalgia: systematic review and meta-analysis of randomized trials. Open Rheumatol J (2009) 1.02

The effectiveness of hydrotherapy in the management of fibromyalgia syndrome: a systematic review. Rheumatol Int (2008) 1.00

A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome. Arthritis Rheum (2008) 0.98

Prevalence of fibromyalgia in a low socioeconomic status population. BMC Musculoskelet Disord (2009) 0.97

Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis. Clin Exp Rheumatol (2012) 0.96

A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia. Semin Arthritis Rheum (2011) 0.94

A meta-analysis of the efficacy of fibromyalgia treatment according to level of care. Arthritis Res Ther (2008) 0.94

[Psychotherapy in patients with fibromyalgia syndrome]. Schmerz (2008) 0.92

Chiropractic management of fibromyalgia syndrome: a systematic review of the literature. J Manipulative Physiol Ther (2009) 0.91

[Multicomponent therapy for treatment of fibromyalgia syndrome]. Schmerz (2008) 0.91

[Alternative and complementary therapies in fibromyalgia syndrome]. Schmerz (2008) 0.91

Improving depiction of benefits and harms: analyses of studies of well-known therapeutics and review of high-impact medical journals. Med Care (2007) 0.91

[Physiotherapy, exercise and strength training and physical therapies in the treatment of fibromyalgia syndrome]. Schmerz (2008) 0.90

Physical therapy in the treatment of fibromyalgia. Scand J Rheumatol Suppl (2000) 0.88

[Pharmacological treatment of fibromyalgia syndrome]. Schmerz (2008) 0.87

Mind-body therapies for the treatment of fibromyalgia. A systematic review. J Rheumatol (2000) 0.85

Prospective epidemiological observations on the course of the disease in fibromyalgia patients. J Negat Results Biomed (2003) 0.84

Are antidepressants effective in fibromyalgia? Joint Bone Spine (2002) 0.79

Chiropractic treatment for fibromyalgia: a systematic review. Clin Rheumatol (2009) 0.78

Articles by these authors

Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet (2008) 13.15

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA (2006) 11.71

GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol (2011) 10.02

Internet-based learning in the health professions: a meta-analysis. JAMA (2008) 8.74

Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet (2006) 8.61

Randomized trials stopped early for benefit: a systematic review. JAMA (2005) 8.43

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol (2007) 7.79

Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res (2004) 7.20

Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid (2011) 7.17

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med (2007) 6.68

High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med (2013) 6.56

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 6.48

Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA (2008) 6.39

Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA (2010) 5.90

Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med (2012) 5.67

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58

Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA (2002) 5.57

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.57

We need minimally disruptive medicine. BMJ (2009) 5.35

A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds. N Engl J Med (2015) 5.28

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ (2008) 5.16

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2008) 4.90

A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. CMAJ (2002) 4.84

Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 4.73

Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2008) 4.68

Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58

Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ (2004) 4.53

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49

Internet versus mailed questionnaires: a randomized comparison (2). J Med Internet Res (2004) 4.45

The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med (2009) 4.41

Need for expertise based randomised controlled trials. BMJ (2005) 4.34

An observational study of orthopaedic abstracts and subsequent full-text publications. J Bone Joint Surg Am (2002) 4.25

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials. Hepatology (2010) 4.19

Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol (2002) 4.19

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol (2007) 4.06

Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2009) 4.04

Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2012) 4.02

Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96

Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA (2009) 3.81

The idolatry of the surrogate. BMJ (2011) 3.81

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 3.80

A new 'mechanistic-practical" framework for designing and interpreting randomized trials. J Clin Epidemiol (2008) 3.75

Development of a theory of implementation and integration: Normalization Process Theory. Implement Sci (2009) 3.68

The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials (2002) 3.62

Physicians' and patients' choices in evidence based practice. BMJ (2002) 3.57

Instructional design variations in internet-based learning for health professions education: a systematic review and meta-analysis. Acad Med (2010) 3.56

GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol (2011) 3.54

Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ (2010) 3.54

Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev (2011) 3.44

Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract (2011) 3.40

Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab (2010) 3.40

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ (2009) 3.39

Barriers to full-text publication following presentation of abstracts at annual orthopaedic meetings. J Bone Joint Surg Am (2003) 3.36

Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol (2002) 3.36

Validity of composite end points in clinical trials. BMJ (2005) 3.26

Quality of care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis. BMJ (2009) 3.22

Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysis. AIDS (2013) 3.17

Internal fixation compared with arthroplasty for displaced fractures of the femoral neck. A meta-analysis. J Bone Joint Surg Am (2003) 3.14

Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis. CMAJ (2010) 3.13

Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc (2007) 3.12

Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ (2007) 3.06

Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ (2013) 3.05

The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med (2008) 3.01

How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ (2005) 2.97

Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 2.95

Does ratification of human-rights treaties have effects on population health? Lancet (2009) 2.93

Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care (2004) 2.93

Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol (2007) 2.93

Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res (2005) 2.91

Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. Ann Intern Med (2012) 2.91

Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med (2007) 2.82

Progress in evidence-based medicine. JAMA (2008) 2.77

Payments for care at private for-profit and private not-for-profit hospitals: a systematic review and meta-analysis. CMAJ (2004) 2.76

Multidisciplinary rehabilitation for subacute low back pain: graded activity or workplace intervention or both? A randomized controlled trial. Spine (Phila Pa 1976) (2007) 2.74

Investing in deliberation: a definition and classification of decision support interventions for people facing difficult health decisions. Med Decis Making (2010) 2.73

Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation (2013) 2.73

Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ (2012) 2.69

Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid. J Clin Epidemiol (2011) 2.69

A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med (2004) 2.68

Operative management of displaced femoral neck fractures in elderly patients. An international survey. J Bone Joint Surg Am (2005) 2.68

Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol (2008) 2.66

Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc (2007) 2.63

Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol (2008) 2.61

Internet versus mailed questionnaires: a controlled comparison (2). J Med Internet Res (2004) 2.59

Understanding patients' experiences of treatment burden in chronic heart failure using normalization process theory. Ann Fam Med (2011) 2.59

Clinical expertise in the era of evidence-based medicine and patient choice. ACP J Club (2002) 2.58